|
Jan 28
|
New Strong Buy Stocks for January 28th
|
|
Jan 25
|
Eton Pharmaceuticals price target raised to $23 from $18 at Craig-Hallum
|
|
Jan 24
|
Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength?
|
|
Jan 3
|
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
|
|
Oct 3
|
Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen
|
|
Aug 2
|
Shareholders in Eton Pharmaceuticals (NASDAQ:ETON) are in the red if they invested five years ago
|
|
Jul 30
|
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
|
|
Jul 15
|
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
|
|
Jun 22
|
Are Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
|
|
May 12
|
Eton Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations
|
|
May 10
|
Q1 2024 Eton Pharmaceuticals Inc Earnings Call
|
|
May 9
|
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
|
|
May 7
|
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) On The Verge Of Breaking Even
|
|
May 1
|
Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
|
|
Apr 30
|
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
|
|
Apr 29
|
Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
|
|
Mar 22
|
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
|
|
Mar 15
|
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2023 Earnings Call Transcript
|
|
Mar 15
|
Q4 2023 Eton Pharmaceuticals Inc Earnings Call
|
|
Mar 14
|
Eton Pharmaceuticals Inc (ETON) Reports Robust Sales Growth and Pipeline Progress in Q4 and ...
|